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Background: When ascending to the high altitude, people living in low altitude
areas will suffer from acute mountain sickness. The aim of this study is to test the
hypothesis that whether an oxygen concentration membrane can be made and
used to construct a new portable oxygen enrichment device for individuals in
acute exposure to the high altitude.
Methods: The membrane was fabricated using vinylsiloxane rubber,
polyphenylene oxide hydrogen silicone polymers, chloroplatinic acid and
isopropyl alcohol. The membrane was assembled in a frame and the performance
was tested in terms of concentration of oxygen, flow rate of oxygen enriched air,
pressure ratio across the membrane and ambient temperature. Furthermore, the
oxygen concentration device was constructed using the membrane, a DC fan,
vacuum pump and gas buffer. A nonrandomized preliminary field test was
conducted, in which eight healthy male subjects were flown to Tibet (Lhasa,
3,700 m). First, subjects wore the oxygen enrichment device and performed an
incremental exercise on cycle ergometer. The test included heart rate (HR),
saturation of peripheral oxygen (SpO2) and physical work capacity (PWC). Then,
after a rest period of 4 hours, the experimental protocol was repeated without
oxygen enrichment device.
Results: The testing showed that the membrane could increase the oxygen
concentration by up to 30%. Simulation test indicated that although the
performance of the oxygen enrichment device decreased with altitudes, the
oxygen concentration could still maintain 28% with flow rate of enriched air
110 cm3/s at 5000 m. The field test showed that higher SpO2, lower HR, and
better PWC (measured by the PWC-170) were observed from all the subjects
using oxygen enrichment device compared with non-using (P < 0.01).
Conclusions: We concluded that the new portable oxygen enrichment device
would be effective in improving exercise performance when ascending to the high
altitude.
Keywords: Medical devices, Hypoxia, Oxygen enrichment membrane, High altitude© 2013 Shen et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
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Qinghai-Tibet Plateau is the highest plateau of the world with an average altitude of
over 4,500 m, which is called the roof of the world. In recent years, with the opening
of Qinghai-Tibet railway in China, more and more people who live in low altitude
areas ascend to high altitude for science investigation, tour or business. Many of
them suffer from acute mountain sickness, experiencing hypoxia which is caused by
the low partial pressure of oxygen at high altitudes [1,2]. The most common symp-
toms include headache, nausea, poor appetite, fatigue, insomnia and dizziness, which
often occur within the first three days of arrival at high altitude [3]. Moreover, a re-
duction in exercise capacity on ascent to altitude is universal, it happens to all low-
landers [4]. This problem may severely affect the physical and mental state, hence
deteriorate work efficacy for the travelers and workers.
To diminish the risk of acute mountain sickness (AMS), numerous instruments
have been developed, including portable hyperbaric chamber [5-7], bottled oxy-
gen [8], and oxygen enrichment room [2]. The oxygen provided by these instru-
ments elevates the oxygen concentration and lowers the equivalent altitude
[9,10], which can treat mild AMS. However, none of them can be easily used by
individuals for a long time. To overcome the limitations, we have developed a
long-lasting and portable anti-hypoxia equipment, the oxygen-increased respir-
ator (OIR) for individuals [11]. While showing improved performance, the OIR
suffers from its own limitation that it needs additional pressure to compress the
air in order to raise the oxygen density without increasing the oxygen concentra-
tion (percentage of oxygen in volume). This sometimes causes irritation when air
temperature is low [11].
By raising the concentration of oxygen in the air, the oxygen partial pressure can be
increased and the hypoxia effects of the high altitude can be reduced [2]. It has been
shown that increasing the oxygen concentration of the air by 1% (e.g. from 21% to
22%) results in a reduction of equivalent altitude of about 300 m [12]. So, providing
lowlanders with oxygen enriched air (the oxygen concentration >21%) would improve
their performance [13]. Because the output enriched air has higher concentration, there
is no need to apply compression to the air before being delivering into nose, which
should comfort the users.
The oxygen enrichment membrane is a kind of gas separation membrane, which
can be used to obtain oxygen enriched air because the oxygen permeates the mem-
brane faster than nitrogen. It was reported that the oxygen concentration of the air
can accumulate up to 40% [14]. It has been widely used in industry, such as steel, en-
gine, and chemistry, in order to induce the complete combustion, save energy and re-
duce pollution [15].
It is therefore natural to hypothesize that such oxygen enrichment membrane could
be used to develop a portable oxygen enrichment device that would help travelers
ease their discomforts when ascending to highland. Oxygen enrichment membranes
were custom-made and tested for various pressure differences and ambient tempera-
tures. In addition, oxygen enrichment devices were invented and investigated in a
hypobaric chamber for various simulated altitudes. Furthermore, a self-controlled
study in Lhasa city (altitude: 3700 m), Tibet was performed to examine the actual
effects for human subjects.
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Ethics statement
The study was approved by the Institutional Ethical Review Board at the Fourth Military
Medical University, Xi’an, China.Oxygen enrichment membrane
Vinylsiloxane rubber and polyphenylene oxide (6:4 in mass) were dissolved into solv-
ent of cyclohexane in room temperature. In addition, hydrogen silicone polymers,
chloroplatinic acid and isopropyl alcohol (1:2:2.5 × 10−5 in amount of substance) were
dissolved in the above solution. After reaching equilibrium, the solution was coated on
the surface of the substrate of polysulfone membrane. The coated membrane was
heated before it is available as the oxygen enrichment membrane for later use (patent
pending, No. 201210309573.3).
An oxygen enrichment membrane unit (Figure 1) included a rectangular frame that
supported two pieces of oxygen enrichment membrane (8.5 cm × 8.5 cm each) between
which, there are multiple layers of nylon net. A vacuum controller with digital display
(ANB, Xin Wei Cheng, Co., Ltd, Chengdu, China) is used to suck oxygen enriched air
out from within the two pieces of membrane. The vacuum degree inside the membrane
unit can be clamped at various values by the vacuum controller, and the pressure differ-
ences across the membrane can then be calculated by baric pressure minus the vacuum
degree. Ambiance temperatures (−10°C–50°C) were simulated in an temperature-
controlled chamber. Flow rate of oxygen was measured by a glass rotor flow meter
(LZB-6 M, Ruiming Instrument, Changzhou, China). Enriched air was analysed by an
oxygen analyzer (Oxymat 61, Siemens, Germany). To test the membrane, concentration
of oxygen and flow rate of enriched air were examined at various pressure difference
across the oxygen enrichment membrane at altitude of 400 m at temperature 25°C. In
addition, concentration of oxygen and flow rate of oxygen enriched air were also mea-
sured at various temperatures at altitude of 400 m with pressure difference of 70 kPa.Figure 1 An oxygen enrichment membrane unit testing system. The system contains 1) membrane
unit; 2) vacuum controller; 3) flow meter; 4) oxygen analyzer. The Green rectangular framework supports the
whole structure. The blue part is a piece of membrane (another invisible piece is on the opposite side),
which is torn apart to show the supporting nylon layers (red). The red part is the multiple nylon layers
which lie in the middle and support the membrane. Two outlets (top) can be used to suck air by a vacuum
pump (not shown).
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Based on the oxygen enrichment membrane, the portable oxygen enrichment device
for individuals was invented (Figure 2). The body of the device is composed of four
parts: a small DC fan (for ventilation), oxygen enrichment membrane units (16 units in
parallel), a vacuum pump (non-oil piston pump), and a buffer (a cylinder, 40 mm in
diameter, and 50 mm in height). Since piston pump produces unstable air flow and
noises, the buffer is designed to avoid both of these disadvantages. The device can pro-
vide oxygen enriched air to respiratory tract by using a disposable medical oxygen mask.
The total weight is 2.7 kg, and the dimensions of machine body are 200 mm × 180 mm ×
84 mm. For convenience of carrying, it can use rechargeable Li-ion batteries (11.1 V, 7800
mAh, 0.6 kg), which can work continuously for more than 2 hours (Figure 3). With this
vacuum pump loading the membrane units, the pressure difference across the membrane
was 90 kPa at 1 atm and 25°C. In this study, 8 such devices were fabricated.Performance in hypobaric chamber
Eight oxygen enrichment devices were placed inside a hypobaric chamber situated in the
school of aerospace medicine at the fourth military medical university. Different altitudes
were simulated (400 m, 2000 m, 3000 m, 3500 m, 4000 m, 4500 m, 5000 m, and 5500 m).
Concentration of oxygen was measured by an oxygen analyzer. Flow rate of oxygen
enriched air at the outlet of the device was measured by the glass rotor flow meter.Field test in Lhasa
Eight young men (22–24 years old, Han nationality) in Xi’an city (400 m) were screened
based on questionnaire before ascending to Lhasa. Exclusion criteria included cardiac
illness, diuretic use, chronic medical conditions, or previous experience of AMS. After
signing informed consent forms, they were flown to Lhasa for the first time.
On arrival, all the subjects were asked to have a rest for 2 hours and prepare for the
test. First, the subjects were asked to sit down in chairs. heart rate (HR) and saturation
of peripheral oxygen (SpO2) at rest state were recorded by a multi-parameter patient
monitor (IntelliVue MP70, Philips, Eindhoven, Netherlands). After that, the subjects
were asked to use the oxygen enrichment devices for 30 minutes. HR and SpO2 were
recorded again.Figure 2 Production of oxygen enrichment device. 1) machine body; 2) bag; 3) disposable medical
oxygen mask; 4) battery; 5) switch; 6) joint of oxygen enriched air outlet.
Figure 3 Schematic diagram of the oxygen enrichment device.
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secutive workloads on a cycle ergometer (839E, Monark Exercise AB, Sweden) with the
oxygen enrichment devices. Subjects were asked to keep the ergometer running at around
60 rpm. Loaded power of the ergometer was initially set to 50 W, then increased by a step
of 50 W per 3 minutes until reaching 200 W [16]. A linear regression was conducted and
the value of power at HR = 170 beat/min was then predicted by the regression equation.
The PWC-170 test was repeated without the devices after 4 hours of resting.Statistical analysis
All of the data were shown as means ± SD. SPSS software (ver. 13.0, SPSS Inc., Chicago,
IL, USA) was used to perform statistical tests. The paired t-test was applied for compari-
son of HR, SpO2 and PWC-170 between two groups after normality test (Shapiro-Wilk
test). Exponential fitting was applied to reveal the relationship of flow rate and concentra-
tion with respect to pressure ratio. Pearson correlation coefficient was applied to indicate
the correlation between parameters (temperature, concentration, flow rate and altitude).
P < 0.01 was considered statistically significant.Results
Characteristics of the oxygen enrichment membrane
The relationships of concentration of oxygen and flow rate of oxygen enriched air as
functions of pressure ratio across the membrane of the unit were shown in Figure 4.
The exponential fitting of concentration of oxygen vs. pressure ratio was y = ‐ 18.41 *
exp(‐ x/1.79) + 31.92 (adjusted R2 = 0.998, ANOVA, P < 0.01). In the mean time, the ex-
ponential fitting of flow rate of oxygen enriched air vs. pressure ratio was y = − 23.17 *
exp(‐ x/0.92) + 8.16 (adjusted R2 = 0.915, ANOVA, P < 0.01).
In addition, the concentration of oxygen was reversely correlated with temperature
(n = 8; Pearson correlation coefficient, R = −0.932, P < 0.01) while the flow rate of oxy-
gen enriched air was positively correlated with temperature (n = 8; Pearson correlation
coefficient, R = 0.988, P < 0.01); see Figure 5.Effects of different altitudes on the oxygen enrichment device
The concentration of oxygen and the flow rate of oxygen enriched air at the outlet of 8
oxygen enrichment devices were found inversely correlated with the simulated altitudes
in the hypobaric chamber (R = −0.892, −0.903 respectively, P < 0.01; Figure 6).
Figure 4 Concentration of oxygen and flow rate of oxygen enriched air as functions of the pressure
ratio across the oxygen enrichment membrane at altitude of 400 m at temperature 25°C.
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The concentration of oxygen of device can be increased to 30%, which is examined by
oxygen analyzer at 3,700 m. Its air flow rate of oxygen enriched air can reach more
than 7 L/min, which is examined at the same altitude.
The results showed that the subject with oxygen enrichment device had a higher SpO2
and lower heart rate at rest than the same subject without devices (P < 0.01). Moreover,
based on the consecutive workloads test, the power output of the subject with oxygen en-
richment device was better than that when without oxygen device (P < 0.01, Table 1).Figure 5 Concentration of oxygen and flow rate of oxygen enriched air as functions of temperature
at altitude of 400 m with pressure difference of 70 kPa.
Figure 6 Simulation in hypobaric chamber. The concentration of oxygen and flow rate drop as altitude
is increasing. The pressure difference between the input and output of the device was set to 90 kPa.
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To reduce the risk of AMS when ascending to high altitude, many medical devices or fa-
cilities have been invented, including bottled oxygen, portable hyperbaric chamber and
oxygen enrichment room. These devices can raise the oxygen concentration and reduce
the equivalent altitude, which can be used to treat mild AMS [12,17]. In this study, we
have applied an alternative way by inventing a new oxygen enrichment device by utilizing
custom-made oxygen enrichment membrane.
We have shown that, following the increase of the pressure across the membrane, the
concentration of oxygen and the flow rate of oxygen enriched air are linearly correlated.
Therefore, it is possible to design a device by multiple pieces of parallelized membranes
with appropriate pressure via a vacuum pump. By adjusting the pressure and area of the
membrane, usable enriched air with appropriate concentration of oxygen and flow rate of
the oxygen can be achieved. Such oxygen enrichment device has been manufactured and
tested in hypobaric chamber and in Lhasa at high altitude (3700 m). As a portable, dur-
able, and convenient device, the oxygen enrichment device can increase oxygen concen-
tration from 21% to 30% at altitude below 400 m. Its flow rate of oxygen enriched air can
reach 116 cm3/s.
The field test in Lhasa has shown that the subjects performed with significant improve-
ments in HR, SpO2 and PWC-170 wearing the device comparing to non-device condi-
tions. SpO2, the indirect measure of the ratio of oxyhemoglobin to the total concentration
of hemoglobin present in the blood, serves as an important indicator of oxygen supply forTable 1 Changes in HR, SpO2, and PWC-170 at 3,700 m (Mean ± SD, n = 8)
Rest Exercise
HR (beat/min) SpO2 (%) PWC-170 (W)
Without device 83.00 ± 2.07 87.50 ± 1.51 201.26 ± 6.46
With device 75.00 ± 2.73* 95.75 ± 1.04* 230.43 ± 6.81*
Note: *P<0.01. ‘Without device’ vs. ‘With device’. PWC-170 is the predicted power at HR = 170 beat/min, calculated from
linear regression, see Materials and methods for detail.
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tial pressure of oxygen stemming from the reduced barometric pressure caused less oxy-
gen diffuse into the capillaries within the lungs, finally caused hypoxia and low SpO2. A
higher level of SpO2 should protect cardiopulmonary function during acute exposure to
low atmospheric pressure, and may also play an important role in reducing heart over-
load. Heart rate, having a close relationship to oxygen consumption, increases following
ascent to high altitude. The lowered heart rate by wearing the device indicated improved
oxygen consumption.
The PWC-170 has also been shown to be a valid tool both in low altitude and high
altitude areas [11,18]. The performance improvement of the subjects wearing the device
may be explained by the oxygen increase in the air they breathed, which thereafter es-
calated the partial pressure of oxygen in blood after oxygen diffuses into the capillaries
within the lungs.
The current device have overcome the limitation of the previous OIR [11] in that the
air pressure delivered into the user’s nasal mask is only slightly higher than local baromet-
ric pressure with moderate elevated temperature, which reduces the discomfort of users.
One limitation of the current experimental design in field test is that all the subjects
performed tests with oxygen enrichment device first. In future work, more independent
experiments concerning the order should be designed. Another limitation is that the
disposable medical oxygen masks without reservoir bag are employed as the patient
interface, which may be sufficient during exhalation but insufficient during inhalation.
To improve the efficiency, a mask with the right volume of reservoir bag should be
matched to our device.
Conclusion
The oxygen enrichment device can not only increase the level of SpO2 and physical
capacity, but also reduce the heart rate, which can play an important positive role in
the protection of people when ascending to high altitude before being acclimatized.
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